本季度信息
华润医药公告显示，第一财季营收为559.41亿元，同比去年同期的549.30亿元增长1.84%。根据披露的财务数据，企业整体营业成本约524.85亿元，毛利率约为6.18%，经营利润率约为1.18%。同期，公司经营活动产生的现金流量净额约为-58.99亿元。公告同时指出，本报告所含信息仅包括华润医药商业的财务数据，并不完全反映华润医药整体经营及财务表现。
业务分项
华润医药商业报告期内销售费用与管理费用合计约为19.40亿元，占收入比重约3.47%。研发投入约0.09亿元，占营业收入比重约0.02%。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.